OnCore Biopharma
Doylestown
About OnCore Biopharma
OnCore Biopharma, Inc. is a privately held biotechnology company focused on the research, development, and commercialization of therapies for the treatment of chronic hepatitis B virus (HBV) infection. OnCore has assembled a portfolio of novel product candidates with unique mechanisms of action for the treatment of hepatitis B and is focused on delivering a cure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Funding stage: M&A
- Last round: Debt Financing (Oct 2014)
- Website: oncorebiopharma.com
- Phone: (215) 489-4928
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncore-biopharma-3207292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.